Cancer BiologyCell ReportsPeer-reviewed
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas
Priyanka D. Sehgal, Ammar S. Naqvi, Makenna Higgins…·Andrei Thomas‐Tikhonenko
The paper identifies a NRCAM proteoform with skipped microexons as a targetable surface antigen in pHGG and demonstrates its utility in immunotherapy.
6 citations